Studies showed that caffeine could improved fatty liver in ApoE KO mice with NAFLD in vivo (47) and NSAID-activated gene-1 (NAG-1), or growth differentiation factor-15 (GDF15), is associated with NAFLD (48). This evidence concerns the gene GDF15 and metabolic dysfunction-associated steatotic liver disease.